Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial (Q42694781)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 February 2003
edit
Language Label Description Also known as
English
Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial
scientific article published on 13 February 2003

    Statements

    Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial (English)
    Giuseppe Gerna
    Daniele Lilleri
    Fausto Baldanti
    Maria Torsellini
    Giovanna Giorgiani
    Marco Zecca
    Piero De Stefano
    Jaap Middeldorp
    M Grazia Revello
    13 February 2003
    5053-5060

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit